Literature DB >> 23114605

Advances in stem cell therapy for spinal cord injury.

Andrea J Mothe1, Charles H Tator.   

Abstract

Spinal cord injury (SCI) is a devastating condition producing great personal and societal costs and for which there is no effective treatment. Stem cell transplantation is a promising therapeutic strategy, though much preclinical and clinical research work remains. Here, we briefly describe SCI epidemiology, pathophysiology, and experimental and clinical stem cell strategies. Research in stem cell biology and cell reprogramming is rapidly advancing, with the hope of moving stem cell therapy closer to helping people with SCI. We examine issues important for clinical translation and provide a commentary on recent developments, including termination of the first human embryonic stem cell transplantation trial in human SCI.

Entities:  

Mesh:

Year:  2012        PMID: 23114605      PMCID: PMC3484454          DOI: 10.1172/JCI64124

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  128 in total

Review 1.  Mesenchymal stem cells as trophic mediators.

Authors:  Arnold I Caplan; James E Dennis
Journal:  J Cell Biochem       Date:  2006-08-01       Impact factor: 4.429

Review 2.  Mesenchymal stromal cells.

Authors:  Armand Keating
Journal:  Curr Opin Hematol       Date:  2006-11       Impact factor: 3.284

3.  Cellular composition of long-term human spinal cord- and forebrain-derived neurosphere cultures.

Authors:  Jing-Hua Piao; Jenny Odeberg; Eva-Britt Samuelsson; Anders Kjaeldgaard; Scott Falci; Ake Seiger; Erik Sundström; Elisabet Akesson
Journal:  J Neurosci Res       Date:  2006-08-15       Impact factor: 4.164

4.  Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

Authors:  R Ramasamy; E W-F Lam; I Soeiro; V Tisato; D Bonnet; F Dazzi
Journal:  Leukemia       Date:  2006-12-14       Impact factor: 11.528

5.  Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury.

Authors:  Yaniv Ziv; Hila Avidan; Stefano Pluchino; Gianvito Martino; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-22       Impact factor: 11.205

Review 6.  Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations.

Authors:  Charles H Tator
Journal:  Neurosurgery       Date:  2006-11       Impact factor: 4.654

7.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

8.  Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury.

Authors:  Eva Syková; Ales Homola; Radim Mazanec; Hynek Lachmann; Simona Langkramer Konrádová; Petr Kobylka; Radek Pádr; Jirí Neuwirth; Vladimír Komrska; Vladimir Vávra; Jan Stulík; Martin Bojar
Journal:  Cell Transplant       Date:  2006       Impact factor: 4.064

9.  Oligodendrocytes and radial glia derived from adult rat spinal cord progenitors: morphological and immunocytochemical characterization.

Authors:  Iris Kulbatski; Andrea J Mothe; Armand Keating; Yoji Hakamata; Eiji Kobayashi; Charles H Tator
Journal:  J Histochem Cytochem       Date:  2006-11-13       Impact factor: 2.479

Review 10.  Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey?

Authors:  M Wyndaele; J-J Wyndaele
Journal:  Spinal Cord       Date:  2006-01-03       Impact factor: 2.772

View more
  82 in total

Review 1.  Cellular therapy for treatment of spinal cord injury in Zebrafish model.

Authors:  Akram Tayanloo-Beik; Zahra Rabbani; Faezeh Soveyzi; Sepideh Alavi-Moghadam; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Babak Arjmand; Bagher Larijani
Journal:  Mol Biol Rep       Date:  2021-01-18       Impact factor: 2.316

2.  Motoneuron intrinsic properties, but not their receptive fields, recover in chronic spinal injury.

Authors:  Michael D Johnson; Elma Kajtaz; Charlette M Cain; C J Heckman
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

3.  Injectable polypeptide hydrogels via methionine modification for neural stem cell delivery.

Authors:  A L Wollenberg; T M O'Shea; J H Kim; A Czechanski; L G Reinholdt; M V Sofroniew; T J Deming
Journal:  Biomaterials       Date:  2018-04-05       Impact factor: 12.479

Review 4.  Hair follicle stem cells: In vitro and in vivo neural differentiation.

Authors:  Nowruz Najafzadeh; Banafshe Esmaeilzade; Maryam Dastan Imcheh
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

Review 5.  Engineering Stem Cells for Biomedical Applications.

Authors:  Perry T Yin; Edward Han; Ki-Bum Lee
Journal:  Adv Healthc Mater       Date:  2015-03-13       Impact factor: 9.933

6.  Immunosuppression of allogenic mesenchymal stem cells transplantation after spinal cord injury improves graft survival and beneficial outcomes.

Authors:  Abel Torres-Espín; Elena Redondo-Castro; Joaquim Hernandez; Xavier Navarro
Journal:  J Neurotrauma       Date:  2015-01-22       Impact factor: 5.269

7.  Electrical stimulation of transplanted motoneurons improves motor unit formation.

Authors:  Yang Liu; Robert M Grumbles; Christine K Thomas
Journal:  J Neurophysiol       Date:  2014-05-21       Impact factor: 2.714

Review 8.  Rewiring the spinal cord: Direct and indirect strategies.

Authors:  Maria Teresa Dell'Anno; Stephen M Strittmatter
Journal:  Neurosci Lett       Date:  2016-12-19       Impact factor: 3.046

9.  BDNF-hypersecreting human umbilical cord blood mesenchymal stem cells promote erectile function in a rat model of cavernous nerve electrocautery injury.

Authors:  Lujie Song; Jianqiang Zhu; Xiong Zhang; Zhiqiang Cui; Qiang Fu; Jianwen Huang; Hongkai Lu
Journal:  Int Urol Nephrol       Date:  2015-11-17       Impact factor: 2.370

10.  Protection and Repair After Spinal Cord Injury: Accomplishments and Future Directions.

Authors:  W Dalton Dietrich
Journal:  Top Spinal Cord Inj Rehabil       Date:  2015-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.